Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a significant drop in short interest in May. As of May 31st, there was short interest totalling 16,000 shares, a drop of 33.9% from the May 15th total of 24,200 shares. Based on an average daily volume of 44,700 shares, the days-to-cover ratio is currently 0.4 days. Approximately 2.2% of the shares of the stock are sold short.

Avalon GloboCare Trading Up 1.0%

NASDAQ:ALBT opened at $3.03 on Wednesday. Avalon GloboCare has a 12-month low of $2.11 and a 12-month high of $12.60. The stock has a 50-day moving average price of $3.60 and a 200 day moving average price of $4.17. The stock has a market capitalization of $5.73 million, a P/E ratio of -0.15 and a beta of 0.03.

Avalon GloboCare (NASDAQ:ALBT) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($1.43) earnings per share for the quarter.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.